(Q35613764)

9 August 2017

1 reference

title

Psychosis of Alzheimer's disease: clinical characteristics and history (English)

1 reference

9 August 2017

0 references

1 reference

Lon S Schneider

1

1 reference

9 August 2017

Karen S Dagerman

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Journal of Psychiatric Research

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

105-111

1 reference

A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Delusional misidentification in Alzheimer's disease: a summary of clinical and biological aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Cognitive deficits of patients with Alzheimer's disease with and without delusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Psychiatric symptoms in patients with dementia predict the later development of behavioural abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Cerebral correlates of psychotic symptoms in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Delusions in newly admitted residents of nursing homes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Psychosis of Alzheimer disease: validity of the construct and response to risperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

A metaanalysis of controlled trials of neuroleptic treatment in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900092-X

10.1016/S0022-3956(03)00092-X

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference